• ISBN13: 9780824782160
• Binding: Hardcover
• Subject: Medical, Nursing and Health Sciences
• Publisher: T&F
• Publisher Imprint: Mar Dekker
• Publication Date: February 16, 2000
• Pages: 352
• Original Price: GBP 170.0
• Language: English
• Edition: N/A
• Item Weight: 604 grams

About the Book Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States.<br>This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies presented in Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence promote cholesterol reduction as a highly successful means of preventing heart disease in various populations.<br>Investigates past, current, and upcoming controlled clinical trials of cholesterol-reduction therapies, comparing effects of statins and bile acid sequestrants to triglyceride-lowering drugs and antioxidants.<br>Written by more than 25 distinguished international researchers, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence <br><li>highlights historical studies of dietary trials designed to reduce CHD <br></li><li>covers tests of HMG CoA reductase inhibitors for patients with and without CHD <br></li><li>illuminates CHD risk factors such as diabetes, hypertension, obesity, and smoking <br></li><li>explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors <br></li><li>reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol <br></li><li>and more!<br>Containing over 700 instructive tables, drawings, photographs, and bibliographic citations, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists, pharmacologists, and upper-level undergraduate, graduate, and medical school students in these disciplines.</li>